MENU
DFTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Definium Therapeutics (DFTX) Ownership - Who owns Definium Therapeutics?

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.79B
P/E Ratio
N/A
Total Cash
373.42M
Projected Growth
N/A
Total Debt
40.77M
Revenue
N/A
Risk (Beta)
1.69
Dividend Yield
N/A
Total Cash/Share
2.81
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
DFTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details